TNF and inflammatory bowel disease: A further large nationwide observational study conducted in the United States assessed the VTE risk of IBD patients treated with TNF-α inhibitors or nonbiologic immunomodulating agents such as azathioprine, 6-MP, MTX and cyclosporine [30].